Side-by-side comparison of AI visibility scores, market position, and capabilities
Las Vegas Sands Asia integrated resorts (NYSE: LVS) $11.4B FY2024 revenue; Sands China Macau $8.2B, Marina Bay Sands Singapore $2.93B (+14%), Londoner Macao renovation, competing with Galaxy and Melco.
Las Vegas Sands Corp. is a Las Vegas, Nevada-based integrated resort developer and operator — publicly traded on the New York Stock Exchange (NYSE: LVS) as an S&P 500 Consumer Discretionary component — developing, owning, and operating luxury integrated resort destinations in Macau, China (through Sands China Ltd., 69.4% owned subsidiary listed on Hong Kong Stock Exchange) and Singapore (Marina Bay Sands) through approximately 40,000 employees, following the 2021 sale of its Las Vegas properties (The Venetian, Palazzo, Las Vegas Sands Expo Center) to Apollo Global Management for $6.25 billion. In fiscal year 2024, Las Vegas Sands reported revenues of $11.4 billion (+5.7% year-over-year), with Macao Operations generating $8.2 billion ($4.49B at The Venetian Macao, $2.0B at Sands Macao, Four Seasons Macao, Parisian Macao, and Londoner Macao) and Singapore's Marina Bay Sands generating $2.93 billion (+14.3%). CEO Robert Goldstein leads Las Vegas Sands' strategy of Macau portfolio renovation and Singapore expansion: the Londoner Macao renovation ($2 billion+ investment transforming the former Sands Cotai Central into the Londoner Macao resort) completed its final tower renovations in 2024, while the Marina Bay Sands Tower 3 expansion (adding 1,000 hotel rooms, additional gaming floors, and a new arena for concerts and events) received Singapore government approval targeting 2028 completion.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.